Mach aus dieser Rolle ein Bewerbungsgespräch — ein Lebenslauf und ein Anschreiben, die genau auf das zugeschnitten sind, was dieser Arbeitgeber sucht.
OM Pharma, a Geneva-based biopharmaceutical company, seeks a Medical Affairs Manager to build relationships with KOLs, specialists and GPs. You will provide scientific information, organize advisory boards, and monitor clinical studies while ensuring regulatory compliance.
Role requires 3+ years in Medical Affairs/MSL, fluency in German, French and English, and willingness to travel mainly in Switzerland with some international travel. Field-based with 20% presence at Villars-sur-Glâne.
Select how often (in days) to receive an alert:
Our Swiss Affiliate, based in Fribourg, is looking for a Medical Affairs Manager responsible for key products of our Portfolio the Bacterial Lysates. Joining a passionate team and reporting to the Medical Affairs Lead, your mission is to build and nurture strong relationships with KOLs, specialists and GPs.
Your main responsibilities are as follows:
Please note that this a field-based position requiring approximatively 20% presence at our office in Villars-sur-Glâne.
To carry out this mission, we are looking for a person with the following profile:
You describe yourself as a team player who enjoys working in a fast-paced, hands-on and flexible environment. Thanks to your scientific background and capacity for synthesis, you easily assimilate and interpret information and scientific data. You also demonstrate excellent communication skills, which allows you to interact efficiently with various stakeholders.
If you are looking for a position in a dynamic pharmaceutical company where you can make the difference and leave your footprint, apply as soon as possible and join OM Pharma!
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases.
It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections.
The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.